Unlike breast or lung cancer, where EpCAM-positive, higher-shedding CTCs and abundant ctDNA repeatedly enable robust liquid-biopsy workflows, RCC presents a low-shedding, EMT-skewed phenotype with frequent EpCAM loss and lower circulating analyte abundance. Here, EPCAM is linked to lung cancer.